Latest Breaking News On - Bonaventure equity - Page 1 : comparemela.com

FloraWorks Completes $2 25M Series-A Financing For Cannabinoid Research

FloraWorks Completes $2 25M Series-A Financing For Cannabinoid Research
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Bonaventure equityArcview group

Exclusive: FloraWorks Completes $2 25M Series-A Financing For Cannabinoid Research

FloraWorks, a cannabinoid therapeutics company specializing in rare and novel cannabinoids, has successfully completed a $2.25 million Series-A financing round. Leading this significant investment was life sciences venture capital firm, Bonaventure Equity LLC.

Ross obrienAlleh lindquistBonaventure equityArcview group

FloraWorks Closes $2 25M Series-A with Round Led by Bonaventure Equity

FloraWorks Closes $2 25M Series-A with Round Led by Bonaventure Equity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEllen mellodyRoss obrienAsia pacificAlleh lindquistFloraworks holdings incArcview groupBonaventure equityOregon newsfile corpFloraworks holdings inc or companyCannabis pharmaceuticals marketCannabinoid researchConsumer supplement applicationsSleep disordersDestructive neurologicalWorks holdings inc

FloraWorks Closes $2 25M Series-A with Round Led by Bonaventure Equity

FloraWorks Closes $2 25M Series-A with Round Led by Bonaventure Equity
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificEllen mellodyRoss obrienAlleh lindquistFloraworks holdings inc or companyFloraworks holdings incNewsfile corpCannabis pharmaceuticals marketBonaventure equityArcview groupCannabinoid researchConsumer supplement applicationsSleep disordersDestructive neurologicalPharmaceuticals market size

Nalu Bio Announces a $12M Series A to Set a Higher Standard for Cannabinoid Production

/PRNewswire/ Nalu Bio, a producer of chemistry-based, ultra-pure cannabinoids, today announced that it has raised a $12 million Series A funding round. The.

United statesHoward goodwinNalu bioCaitlyn krebsPrnewswire nalu bioPortfolia active aging longevity fundBrown angel groupNalu bio coIntrinsic capital partnersFlybridge capital partnersPortfolia active agingLongevity fundBonaventure equityGolden seedsSacramento angelsNalu bio co founder